Risk factors for low bone mineral density in children and young adults with Crohn's disease

Journal of Pediatrics

Volumn 135, Issue 5, 1999, Pages 593-600

  Semeao, E J ^a   Jawad, A F ^a   Stouffer, N O ^a   Zemel, B S ^a   Piccoli, D A ^a   Stallings, V A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MERCAPTOPURINE;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CHILD; CROHN DISEASE; DISEASE SEVERITY; DRUG EXPOSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; HYPOALBUMINEMIA; LUMBAR SPINE; MAJOR CLINICAL STUDY; NOSE FEEDING; OSTEOPENIA; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; TOTAL PARENTERAL NUTRITION;

EID: 0033505557     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70058-2     Document Type: Article

References (36)

1. RJ Greenstein HD Janowitz DB. Sechar The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients Medicine 55 1976 401 412
2. I Bjarnason A Macpherson C Macintosh M Buxton-Thomas I Forgacs C. Moniz Reduced bone density in patients with inflammatory bowel disease Gut 40 1997 228 233
3. J Jahnsen JA Falch E Aadland P. Mowinckel Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population based study Gut 40 1997 313 319
4. JA Silvennoinen TJ Karttunen SE Niemela JJ Manelius JK. Lentola A controlled study of bone mineral density in patients with inflammatory bowel disease Gut 37 1995 71 76
5. F Pigot C Roux S Chaussade D Hardelin D Pelleter T Montburn Low bone mineral density in patients with inflammatory bowel disease Dig Dis Sci 37 1992 1396 1404
6. JE. Compston Review article: Osteoporosis, corticosteroids and inflammatory bowel disease Aliment Pharmacol Ther 9 1995 237 250
7. Consensus Development Conference Prophylaxis and treatment of osteoporosis Ann J Med 94 1993 646 650
8. SR Cummings JL Kelsey MG Newitt KJ. O’Dowd Epidemiology of osteoporosis and osteoporotic fractures Epidemiol Review 7 1985 178 208
9. NJ Shaw NJ. Bishop Mineral accretion in growing bones: a framework for the future? Arch Dis Child 72 1995 177 179
10. RM Issenman SA Atkinson C Rodja L. Fraher Longitudinal assessment of growth, mineral metabolism and bone mass in pediatric Crohn’s disease J Pediatr Gastroentrol Nutr 17 1993 401 406
11. R Gokhale M Favus T Karrison M Sutton B Rich BS. Kirschner Bone mineral density assessment in children with inflammatory bowel disease Gastroenterology 114 1998 902 911
12. FJ Cowan JT Warner FJ Dunstan WD Evans JW Gregory HR. Jenkins Inflammatory bowel disease and predisposition to osteopenia Arch Dis Child 76 1997 325 329
13. D Herzog N Bishop F Glorieux EG. Seidman Interpretation of bone mineral density values in pediatric Crohn’s disease Inflamm Bowel Dis 4 1998 261 267
14. EJ Semeao AJ Jawad VA Stallings DA. Piccoli Effect of site of disease and steroid exposure on bone mineral density (BMD) in children with Crohn’s disease J Pediatr Gastroenterol Nutr 25 1997 A35
15. CN Bernstein LL Seeger JW Sagre PA Anton L Artinian F. Shanahan Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis J Bone Mineral Res 10 1995 250 256
16. SC Bischoff A Herrmann M Goke MD Manns A Vanzur Muhlen G. Brabant Altered bone metabolism in inflammatory bowel disease AJG 92 1997 1157 1163
17. V Abitbol C Roux S Chaussade S Guillemant S Kolta M Dougados Metabolic bone assessment in patients with inflammatory bowel disease Gastroenterology 108 1995 417 422
18. S Ghosh S Cowen WJ Hannan A. Ferguson Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis Gastroenterology 107 1994 1031 1039
19. M Staun L Tjellesen M Thale D Schaadt S. Jarnum Bone mineral content in patients with Crohn’s disease: a longitudinal study in patients with bowel resection Scand J Gastroenterol 32 1997 226 232
20. TG Lohman AF Roche R. Martorell Anthropometric standardization reference manual 1988 Human Kinetics Books Champaign, IL
21. A. Goldfien Adrenocorticosteroids and adrenocortical antagonists. Basic and clinical pharmacology 3rd ed 1987 Appleton and Lange Norwalk, CT
22. JS Hyams F Mandel GD Ferry JD Gryboski PM Kibort BS Kirschner Relationship of common laboratory parameters to the activity of Crohn’s disease in children J Pediatr Gastroenterol Nutr 14 1992 216 222
23. A. Prentice TJ. Parsons TJ. Cole Uncritical use of bone mineral density in absorptiometry may lead to size related artifacts in the identification of bone mineral determinants Am J Clin Nutr 60 1994 837 842
24. MZ Mazlam HS. Hodgson Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease Gut 33 1992 773 778
25. RB. Sartor Cytokines in intestinal inflammation: pathophysiological and clinical considerations Gastroenterology 106 1994 533 539
26. CL Lin C Moniz TJ Chambers JM. Chow Colitis causes bone loss in rats through suppression of bone formation Gastroenterology 111 1996 1263 1271
27. SC Manolagas RL. Jilka Bone marrow, cytokines and bone remodeling N Engl J Med 332 1995 305 311
28. E. Canalis Effects of tumor necrosis factor on bone formation in vitro Endocrinology 121 1987 1596 1604
29. P Stashenko FE Dewhirst ML Rooney LA Desjardins JD. Heeley Interleukin-1b is a potent inhibitor of bone formation in vitro J Bone Miner Res 2 1987 559 565
30. S. Meghji Bone remodeling Br Dent J 172 1992 235 242
31. H. Cushing The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism) Bull Johns Hopkins Hosp 1 1932 137 192
32. JR. Reid Pathogenesis and treatment of steroid osteoporosis Clin Endocrinol 30 1989 83 103
33. SF. Hodgson Corticosteroid-induced osteoporosis. Metabolic bone disease II Endocrinol Metabol Clin North Am 19 1990 95 111
34. BP Lukart LG. Raisz Glucocorticoid-induced osteoporosis: pathogenesis and management Ann Int Med 112 1990 352 364
35. American College of Rheumatology Task Force on Osteoporosis Guidelines Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis Arthritis Rheum 11 1996 1791 1801
36. P Sambrook J Eisman M Yeates N Pocock S Eberl G. Champion Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids Ann Rheum Dis 45 1986 950 953